Navigation Links
Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
Date:7/2/2012

FORT LAUDERDALE, Fla., July 2, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals Inc. (Pink Sheets: NOUV), a provider of quality all-natural dietary supplements, announced today that the Company is in talks with international mass distribution firms.  

Nouveau Life is in talks with mass distributors in Canada and the UK to sell the Nouveau Life's products in those markets.

"The distribution firms with which we are speaking are well-regarded in their respective countries," stated Nouveau Life CEO Melissa Walker. "These distributors have extensive knowledge of the regulatory requirements in each country. They know how to navigate their governments' oversight systems and will help Nouveau Life in the licensing processes. They also have well-established sales networks in place. These are growing markets. We see great potential for Nouveau Life to penetrate these markets." 

Seventy-one percent of Canadian adults report using a natural health product, with 38 percent reporting they use at least one daily. Canada requires that dietary supplements be licensed prior to market entry. The Natural Health Products Directorate (NHPD), a branch of Health Canada, is responsible for granting licenses for dietary supplements.

In the UK, the dietary supplement and vitamins market is valued at over $1.1 billion (U.S.). The government agency National Health Services (NHS) is responsible for regulating and licensing dietary supplements in the UK.

Nouveau Life currently sells four specialty supplements: Azul Instant™, Azul: Male Enhancer™, New Life Naturals: For Her Senses™, and New Life Naturals: For Your Weight Loss. The Company has plans to release another four products to the public in the coming weeks. All of Nouveau Life's supplements can be purchased by visiting www.nlpnaturals.com.

About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.

CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993

 

 

 


'/>"/>
SOURCE Nouveau Life Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
2. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
3. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
6. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
7. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
8. Pharmaceuticals: Global Industry Almanac, MarketLine
9. Prodigy Health Supplier Partners with Stason Pharmaceuticals to Help Relieve U.S. Drug Shortages
10. Trading Of Onyx Pharmaceuticals Common Stock Halted
11. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... 2016 Elekta today announced that ... be the focal point of seven scientific presentations at ... for Radiotherapy & Oncology, taking place April 29 - ... radiotherapy system and a high-field MRI scanner with sophisticated ... patient,s anatomy in real time. The MR-linac is designed ...
(Date:4/27/2016)... 2016 Tie-up with Government hospitals ... to save newborns   Fortis La Femme, ... in collaboration with Breast Milk Foundation (BMF), a non-profit organization ... Milk Bank, ,Amaara, in Delhi-NCR today. This non-profit centre recognizes ... infants and should be available to babies deprived of mother,s ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Horizon Blue ... with doctors and hospitals to make transformative changes in how health care is ... minds this week in discussing breakthroughs in cellular medicine to treat disease. After ...
(Date:4/28/2016)... ... April 28, 2016 , ... One way to ignore ... This is unfortunately true. But we toss the baby out with the bathwater when ... provides tips for identifying higher-quality studies and otherwise making better use of education policy ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Aesthetic Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing and ... Surgery Collaborative Residency Network. The platform is scheduled to launch in July 2016 ...
(Date:4/28/2016)... MA (PRWEB) , ... April 28, 2016 , ... A ... were typical among 18 states studied, the Workers Compensation Research Institute (WCRI) ... The WCRI study, CompScope™ Benchmarks for Kentucky, 16th Edition , found that indemnity ...
(Date:4/28/2016)... ... April 28, 2016 , ... Metabolic Nutrition today ... this week’s 2016 Europa Games Get Fit and Sports Expo in Orlando, ... Europa Orlando Expo coming up April 29-30, was selected as the perfect event to ...
Breaking Medicine News(10 mins):